Signifor (Pasireotide Extended-Release Injection) and Spravato (56 MG Dose)
Determining the interaction of Signifor (Pasireotide Extended-Release Injection) and Spravato (56 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Signifor, Signifor Injection
Generic Name: esketamine
Brand name: Spravato
Synonyms: Spravato Nasal Spray, Spravato
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Signifor (Pasireotide Extended-Release Injection)-Spravato (84 MG Dose)
- Signifor (Pasireotide Extended-Release Injection)-Sprintec
- Signifor (Pasireotide Extended-Release Injection)-Sprintec 28
- Signifor (Pasireotide Extended-Release Injection)-Spritam
- Signifor (Pasireotide Extended-Release Injection)-Sprix
- Signifor (Pasireotide Extended-Release Injection)-Sprix Nasal Spray
- Spravato (56 MG Dose)-Signifor (Pasireotide Injection)
- Spravato (56 MG Dose)-Signifor Injection
- Spravato (56 MG Dose)-Signifor LAR
- Spravato (56 MG Dose)-Signifor LAR Injection
- Spravato (56 MG Dose)-Siklos
- Spravato (56 MG Dose)-Siladryl Allergy